Breast cancer advocates warn patients face care gaps after treatment ends
Dr Marisa Weiss of Breastcancer.org discusses the lack of support for breast cancer survivors during the quiet phase following initial treatment in an interview with Healthline.
Survivors face questions after care
Public knowledge and support often do not keep pace with high awareness levels, according to Dr Weiss. Patients are frequently left with unanswered questions regarding side effects, work, and family life once initial treatment concludes. Many individuals turn to GLP-1s, supplements, and cannabis without informing their doctors due to fear of judgment.
Potential drug interactions exist
Some substances patients use can interact with cancer medications, yet patients often hide this usage from medical staff. Dr Weiss notes that advocacy and awareness must continue beyond October campaigns to address these ongoing needs. The gap between diagnosis support and long-term care remains a significant issue for the community.
Reported by one outlet
Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.
Reported by
1 independent outlet. Headline as published. Links open the original report.